These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 24984931)
1. Serum thymus and activation-regulated chemokine (TARC) and interleukin-31 levels as biomarkers for monitoring in adult atopic dermatitis. Kyoya M; Kawakami T; Soma Y J Dermatol Sci; 2014 Sep; 75(3):204-7. PubMed ID: 24984931 [No Abstract] [Full Text] [Related]
2. Association of serum interleukin-18 and other biomarkers with disease severity in adults with atopic dermatitis. Kou K; Aihara M; Matsunaga T; Chen H; Taguri M; Morita S; Fujita H; Yamaguchi Y; Kambara T; Ikezawa Z Arch Dermatol Res; 2012 May; 304(4):305-12. PubMed ID: 22146836 [TBL] [Abstract][Full Text] [Related]
3. Serum measurement of thymus and activation-regulated chemokine/CCL17 in children with atopic dermatitis: elevated normal levels in infancy and age-specific analysis in atopic dermatitis. Fujisawa T; Nagao M; Hiraguchi Y; Katsumata H; Nishimori H; Iguchi K; Kato Y; Higashiura M; Ogawauchi I; Tamaki K Pediatr Allergy Immunol; 2009 Nov; 20(7):633-41. PubMed ID: 19236603 [TBL] [Abstract][Full Text] [Related]
4. Variations in serum TARC and I-TAC levels reflect minor changes in disease activity and pruritus in atopic dermatitis. Kimura T; Sugaya M; Suga H; Morimura S; Miyamoto A; Kai H; Kagami S; Yanaba K; Fujita H; Asano Y; Tada Y; Kadono T; Sato S Acta Derm Venereol; 2014 May; 94(3):331-2. PubMed ID: 24104601 [No Abstract] [Full Text] [Related]
5. Thymus and activation-regulated chemokine as a clinical biomarker in atopic dermatitis. Kataoka Y J Dermatol; 2014 Mar; 41(3):221-9. PubMed ID: 24628072 [TBL] [Abstract][Full Text] [Related]
6. Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity. Kakinuma T; Nakamura K; Wakugawa M; Mitsui H; Tada Y; Saeki H; Torii H; Asahina A; Onai N; Matsushima K; Tamaki K J Allergy Clin Immunol; 2001 Mar; 107(3):535-41. PubMed ID: 11240957 [TBL] [Abstract][Full Text] [Related]
7. Thymus and activation regulated chemokines in children with atopic dermatitis: Kyushu University Ishigaki Atopic Dermatitis Study (KIDS). Furusyo N; Takeoka H; Toyoda K; Murata M; Maeda S; Ohnishi H; Fukiwake N; Uchi H; Furue M; Hayashi J Eur J Dermatol; 2007; 17(5):397-404. PubMed ID: 17673383 [TBL] [Abstract][Full Text] [Related]
8. Significant correlation of serum IL-22 levels with CCL17 levels in atopic dermatitis. Hayashida S; Uchi H; Takeuchi S; Esaki H; Moroi Y; Furue M J Dermatol Sci; 2011 Jan; 61(1):78-9. PubMed ID: 21095106 [No Abstract] [Full Text] [Related]
9. Correlation between serum thymus and activation-regulated chemokine levels and stratum corneum barrier function in healthy individuals and patients with mild atopic dermatitis. Furue M; Matsumoto T; Yamamoto T; Takeuchi S; Esaki H; Chiba T; Yamaguchi H J Dermatol Sci; 2012 Apr; 66(1):60-3. PubMed ID: 22391243 [TBL] [Abstract][Full Text] [Related]
10. Case of atopic dermatitis concurrent with idiopathic thrombocytopenic purpura, whose serum thymus and activation-regulated chemokine level remained undetectable. Ozawa M; Sasahara Y; Aiba S J Dermatol; 2018 May; 45(5):606-608. PubMed ID: 29399856 [TBL] [Abstract][Full Text] [Related]
11. Serum levels of thymus and activation-regulated chemokine can be used in the clinical evaluation of atopic dermatitis. Gu CY; Gu L; Dou X Int J Dermatol; 2015 Jul; 54(7):e261-5. PubMed ID: 26108268 [TBL] [Abstract][Full Text] [Related]
12. Serum Thymus and Activation Regulated Chemokine (TARC), IL- 18 and IL-18 Gene Polymorphism as Associative Factors with Atopic Dermatitis. Gohar MK; Atta AH; Nasr MM; Hussein DN Egypt J Immunol; 2017 Jun; 24(2):9-22. PubMed ID: 29528575 [TBL] [Abstract][Full Text] [Related]
13. [Biomarker of atopic dermatits -focusing on serum TARC/CCL17 level as severity marker-]. Saeki H Arerugi; 2013 Feb; 62(2):131-7. PubMed ID: 23531648 [No Abstract] [Full Text] [Related]
14. Different effect of oral cyclosporine therapy and oral antihistamine therapy on serum high-sensitivity C-reactive protein level and thymus and activation-regulated chemokine level in atopic dermatitis in older children and adulthood. Ohtsuka T Int J Dermatol; 2015 Jun; 54(6):648-55. PubMed ID: 25312097 [TBL] [Abstract][Full Text] [Related]
15. Utility of serum thymus and activation-regulated chemokine as a biomarker for monitoring of atopic dermatitis severity. Landheer J; de Bruin-Weller M; Boonacker C; Hijnen D; Bruijnzeel-Koomen C; Röckmann H J Am Acad Dermatol; 2014 Dec; 71(6):1160-6. PubMed ID: 25199679 [TBL] [Abstract][Full Text] [Related]
16. An ultra-sensitive clinical biomarker assay: quantitation of thymus and activation-regulated chemokine in human plasma. Zhao X; Delgado L; Weiner R; Laterza OF Bioanalysis; 2014 Apr; 6(8):1069-80. PubMed ID: 24830891 [TBL] [Abstract][Full Text] [Related]
17. Reduction of serum TARC levels in atopic dermatitis by topical anti-inflammatory treatments. Yasukochi Y; Nakahara T; Abe T; Kido-Nakahara M; Kohda F; Takeuchi S; Hagihara A; Furue M Asian Pac J Allergy Immunol; 2014 Sep; 32(3):240-5. PubMed ID: 25268342 [TBL] [Abstract][Full Text] [Related]
18. Are age-specific high serum IgE levels associated with worse symptomatology in children with atopic dermatitis? Hon KL; Lam MC; Leung TF; Wong KY; Chow CM; Fok TF; Ng PC Int J Dermatol; 2007 Dec; 46(12):1258-62. PubMed ID: 18173519 [TBL] [Abstract][Full Text] [Related]
19. Serum thymus and activation-regulated chemokine, macrophage-derived chemokine and eotaxin as markers of severity of atopic dermatitis. Jahnz-Rozyk K; Targowski T; Paluchowska E; Owczarek W; Kucharczyk A Allergy; 2005 May; 60(5):685-8. PubMed ID: 15813816 [TBL] [Abstract][Full Text] [Related]
20. Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell- attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis. Hijnen D; De Bruin-Weller M; Oosting B; Lebre C; De Jong E; Bruijnzeel-Koomen C; Knol E J Allergy Clin Immunol; 2004 Feb; 113(2):334-40. PubMed ID: 14767451 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]